UK markets open in 2 hours 3 minutes
  • NIKKEI 225

    29,068.95
    +193.72 (+0.67%)
     
  • HANG SENG

    29,210.31
    +327.85 (+1.14%)
     
  • CRUDE OIL

    73.38
    +0.08 (+0.11%)
     
  • GOLD FUTURES

    1,776.00
    -0.70 (-0.04%)
     
  • DOW

    34,196.82
    +322.58 (+0.95%)
     
  • BTC-GBP

    24,921.47
    +1,361.58 (+5.78%)
     
  • CMC Crypto 200

    834.70
    +48.08 (+6.11%)
     
  • ^IXIC

    14,369.71
    +97.98 (+0.69%)
     
  • ^FTAS

    4,051.12
    +11.72 (+0.29%)
     

Tecan to present at UBS Global Healthcare Virtual Conference

  • Oops!
    Something went wrong.
    Please try again later.
·1-min read
  • Oops!
    Something went wrong.
    Please try again later.

Männedorf, Switzerland, May 21, 2021 – The Tecan Group (SIX Swiss Exchange: TECN) today announced that it will present at the UBS Global Healthcare Virtual Conference next week.

UBS Global Healthcare Virtual Conference
Date: 25 May 2021
Presentation and Fireside Chat: 4:00 pm CET (10:00 am EST) with Dr. Achim von Leoprechting, CEO, Tecan
Webcast live under the "Investor Relations" tab of Tecan's website www.tecan.com

A replay of the webcast will be available after the presentation and will remain available for 30 days.

About Tecan
Tecan (www.tecan.com) is a leading global provider of laboratory instruments and solutions in biopharmaceuticals, forensics and clinical diagnostics. The company specializes in the development, production and distribution of automation solutions for laboratories in the life sciences sector. Its clients include pharmaceutical and biotechnology companies, university research departments, forensic and diagnostic laboratories. As an original equipment manufacturer (OEM), Tecan is also a leader in developing and manufacturing OEM instruments and components that are then distributed by partner companies. Founded in Switzerland in 1980, the company has manufacturing, research and development sites in both Europe and North America and maintains a sales and service network in 52 countries. In 2020, Tecan generated sales of CHF 731 million (USD 778 million; EUR 683 million). Registered shares of Tecan Group are traded on the SIX Swiss Exchange (TECN; ISIN CH0012100191).

For further information:

Tecan Group
Martin Braendle
Senior Vice President, Corporate Communications & IR
Tel. +41 (0) 44 922 84 30
Fax +41 (0) 44 922 88 89
investor@tecan.com
www.tecan.com

Attachment


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting